Legacy AI grade · Sources dated 2026-06-01. Not expert reviewed. Coverage is limited to the listed sources. About the new summary workflow

Fisetin for Cognitive Function

Verdict: No human evidence; preclinical only

There is currently no human trial evidence that fisetin improves cognitive function or prevents dementia; all supporting data come from mouse studies, and major regulators and clinics do not endorse this use.

U ⚫ U Unverified Taiwan Regulatory Restriction

🔬Why this grade7-layer evidence engine

This claim is graded Unverified because every cited study is preclinical, with zero published human randomized trials measuring cognitive outcomes. Four mouse experiments report benefit: nano-fisetin eased memory deficits and lowered TNF-alpha/IL-6 in amyloid-beta mice over three weeks (PMID 39552578); fisetin reduced cognitive decline in rapidly aging SAMP8 mice over 28 weeks (PMID 28575152); and it preserved learning and memory in transgenic Alzheimer's mice over 36 weeks (PMID 24341874). A related review covers the fisetin derivative CMS121 but reports no human cognition data (PMID 39422940).

Animal results do not transfer reliably to people, and a practical gap compounds the uncertainty: the preclinical doses (roughly 5-25 mg/kg) far exceed typical human supplement doses, and fisetin is poorly absorbed orally. Ongoing early-phase human trials have not yet reported cognitive results.

Authorities reinforce the cautious grade. The FDA issued a warning letter over illegal disease claims for a fisetin product, and Health Canada permits only a basic antioxidant claim at 100 mg/day, not any anti-aging or cognitive use. Mayo Clinic explicitly argues against using commercial fisetin, and the Alzheimer's Association states no supplement has been proven to benefit cognitive function or brain health.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.41
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
U · Taiwan Regulatory Restriction
Confidence
74%
Broadly consistent
Evidence level
E10
Mechanism / case reports / no human evidence

How strongly each layer supports this effect

lower = less supportive
L11 AI re-checkIndependent read
0.20
L2 PubMedPrimary literature
0.40
L5 Clinical bodiesAuthoritative stance
0.40
L1 ExamineGlobal benchmark
0.50
L3 MechanismPlausibility
0.50
Against Mixed Supports
▸View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.415
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 僅有 E10 級證據 (cohort/animal/mechanism),不足以下結論
  4. tier_strict_requirement_check — C 級條件未達 (需 E1-E8;實際 E10 僅機轉)
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Nanoformulated fisetin ameliorates Alzheimer's disease via reducing proinflammatory cytokines and activating NRF2/HO-1
PMID: 39552578 2024 Animal Study
Finding: Nano-fisetin significantly improved memory and motor deficits, reduced TNF-α/IL-6 and oxidative stress, activated NRF2/HO-1 (p-values not extracted).
🟠 Limited quality
View on PubMed
CMS121, a Novel Drug Candidate for the Treatment of Alzheimer's Disease and Age-Related Dementia
PMID: 39422940 2024 Animal Study
Finding: CMS121 maintains cognitive function in preclinical AD models; IND-enabling toxicology completed; no human cognition data yet.
🟠 Limited quality Academic
View on PubMed
Fisetin Reduces the Impact of Aging on Behavior and Physiology in the Rapidly Aging SAMP8 Mouse
PMID: 28575152 2017 Animal Study
Finding: Fisetin reduced cognitive deficits in old SAMP8 mice and restored synaptic/inflammation markers vs untreated controls.
🟠 Limited quality Government
View on PubMed
Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic mice
PMID: 24341874 2014 Animal Study
Finding: Fisetin prevented learning/memory deficits in AD-Tg mice; treated mice spent significantly more time in target quadrant vs untreated AD mice.
🟠 Limited quality Government
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
Fisetin is a potent anti-inflammatory agent and directly inhibits the activity pro-inflammatory cytokines such as TNFα, NF-κB, and IL6. source↗
L4b EU EFSA
Cautious
L4e WHO
Supportive
Medicinal Ingredient: 3,3',4',7-Tetrahydroxyflavone 100.0 mg. Recommended Use or Purpose: Provides Antioxidant. Provides antioxidants that help protect against the oxidative damage caused by free radicals. Recommended Dose: Adults (19 years and older): 1 capsule daily. Cautions and Warnings: Consult a healthcare practitioner prior to use if you are taking opioids, anti-inflammatory medications,… source↗
L5a NIH Office of Dietary Supplements
Cautious
L5b Mayo Clinic
Cautious
Our findings argue against what many people are already doing — using commercial products like quercetin or related compounds like fisetin that may show some senolytic properties. source↗
✓PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-cognitive-function-INT-fisetin-001 繁體中文版 →